Summary
On April 17, 2026, Cerebras Systems filed publicly for a US IPO on Nasdaq under the ticker CBRS, its second attempt after withdrawing an earlier filing in September 2024 when a national security review of a minority investor blocked it. The company reported $510 million in 2025 revenue and a $10 billion commercial contract with OpenAI as the centerpiece of its S-1. The filing marks the first AI chip infrastructure company — outside NVIDIA — to reach the US public markets in the current AI investment cycle.
What Happened
Cerebras Systems filed an S-1 registration statement with the Securities and Exchange Commission on April 17, 2026, targeting a mid-May 2026 Nasdaq listing under the ticker symbol CBRS. The company is seeking to raise approximately $2 billion in proceeds at a target valuation of $22 to $25 billion.
The filing is Cerebras's second attempt. In September 2024, the company had filed an initial S-1 but was forced to withdraw it after the Committee on Foreign Investment in the United States launched a review of G42, an Abu Dhabi-based AI firm that held a voting stake in Cerebras. CFIUS scrutinized G42's historical ties to Huawei and its potential to serve as an indirect conduit for advanced American AI chip technology. The review concluded in October 2025 after G42's stake was restructured to non-voting shares, removing G42 from governance influence and clearing the path for the refiling.
The S-1 disclosed financial results significantly stronger than at the time of the original withdrawal. Cerebras reported $510 million in 2025 revenue, up 76 percent from $290.3 million in 2024. The company turned profitable on a GAAP basis in 2025, reporting $87.9 million in net income after a $485 million net loss the prior year. Non-GAAP net income for 2025 was $237.8 million.
The commercial relationship with OpenAI is the narrative centerpiece of the filing. Cerebras disclosed a multi-year contract with OpenAI to deliver 750 megawatts of compute capacity through 2028, valued at more than $10 billion. The contract, along with an AWS partnership for inference distribution, entered the Cerebras investor story during the eighteen months between the original filing withdrawal and the April 2026 refiling. Both relationships had been absent from the 2024 S-1.
Cerebras's hardware architecture distinguishes it from all other AI chip companies. Its flagship chip uses wafer-scale integration — the entire silicon wafer, rather than individual dies cut from the wafer, becomes a single chip. The resulting processor contains 4 trillion transistors, 900,000 AI-optimized cores, 44 gigabytes of on-chip SRAM, and 21 petabytes per second of memory bandwidth. The chip is approximately 57 times larger in die area than NVIDIA's H100. CEO Andrew Feldman has described the architecture as "the fastest AI hardware for training and inference."
The IPO is being underwritten by Morgan Stanley, Citigroup, Barclays, and UBS as joint lead underwriters, with Mizuho, TD Cowen, Needham, Craig-Hallum, Wedbush Securities, Rosenblatt, and Academy Securities as additional bookrunners and co-managers.
Why It Matters
The Cerebras IPO filing is the first meaningful test of public market appetite for AI chip infrastructure companies beyond NVIDIA in the current AI cycle. Prior AI-era chip companies — including Arm Holdings, which listed in September 2023 — had reached public markets, but Cerebras is the first company whose business is built entirely on the premise of displacing NVIDIA in the AI training and inference market. Its wafer-scale architecture represents a distinct technical bet rather than an incremental improvement on conventional GPU designs.
The CFIUS episode embedded in the Cerebras history is independently notable. The review established a procedural template: a Middle Eastern investor with historical ties to a Chinese technology firm holds a voting stake in a US AI chip company, triggering a national security review, and the resolution requires converting voting shares to non-voting shares as a condition of clearance. As foreign capital continues to flow into US AI infrastructure — including from Saudi Arabia's PIF, UAE's MGX, and others — the Cerebras CFIUS resolution provides a documented precedent for how Treasury's foreign investment review process has handled this category of investment. The eighteen-month delay between the original filing and the refiling also documents the operational cost of the national security review: Cerebras lost a year-and-a-half of public market access and was forced to raise capital in private rounds during that period.
The interval between the two filings also illustrates the speed of market development in AI infrastructure. The $10 billion OpenAI contract and the AWS inference partnership — both absent from the 2024 filing — were concluded during the review period. A company that filed its 2024 S-1 without a defining anchor customer refiled in 2026 with one of the largest single commercial contracts in the AI sector. Whether the IPO valuation fully reflects this transformation, and whether Cerebras can sustain profitability as it scales compute commitments to OpenAI, are the central questions investors will examine in the months between the filing and any listing.
§ How to read the metadata
- Landmark
- Fundamentally alters the trajectory; 2–5 per year.
- Major
- Meaningfully shifts the landscape; 2–4 per month.
- Notable
- Worth documenting; significance can be upgraded later.
- Confidence
- High = primary sources corroborate. Medium = credible secondary only. Low = provisional. Disputed = credible sources disagree.
- Contestation
- Uncontested = no formal challenge. Contested = at least one challenge open. Superseded = replaced by a later entry. Unresolved = dispute still open.